Related Experiment Videos
Phase II trial of PALA in hypernephroma and urinary bladder cancer
Cancer Treatment Reports
|December 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2016
Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2013
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Preclinical studies of gossypol in prostate carcinoma.
International journal of oncology·2011
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
Autotaxin as a potential biomarker in hepatic encephalopathy: Insights from a mouse model and cirrhotic patients.
Cellular and molecular biology (Noisy-le-Grand, France)·2026
The assembly of tetrameric human L-lactate dehydrogenase is regulated by ionic strength, β-NADH binding, cyclic peptides, and long-chain dicarboxylates.
Protein science : a publication of the Protein Society·2026
Tumour hypoxia in clinical oncology: imaging, therapeutic strategies, and translational challenges.
Clinical and translational radiation oncology·2026